Graf Akcie APTO (Aptose Biosciences Inc). Diskuze k akciím APTO. Aktuální informace APTO.

Základní informace o společnosti Aptose Biosciences Inc (Akcie APTO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	206.22M
Hodnota podniku (EV)	N/A
Tržby	0.00
EBITDA	N/A
Zisk	-57.66
Růst v tržbách Q/Q	N/A %
Růst v tržbách Y/Y	N/A %
P/E (Cena vůči ziskům)	0.00
Forward P/E	-0.02
EV/Sales	N/A
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	N/A
P/FCF	N/A
Price/Book	1.71
Účetní hodnota na akcii	1.35
Hotovost na akcii	1.39
FCF vůči ceně	-18.60 %
Počet zaměstnanců	40
Tržba na zaměstnance	0.00
Profit margin	N/A %
Operating margin	N/A %
Gross margin	N/A %
EBIT margin	N/A %
EBITDA margin	N/A %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	N/A %
EPS - Očekávaný růst příští rok	-39.13 %
Return on assets	-47.76 %
Return on equity	-50.62 %
ROIC	-48.72 %
ROCE	-58.53 %
Dluhy/Equity	0.06
Čistý dluh/EBITDA	15.15
Current ratio	13.67
Quick Ratio	13.67
Volatilita	5.47
Beta	1.00
RSI	42.47
Cílová cena analytiků	11
Známka akcie (dle analytiků)	1.00
Insider ownership	5.10 %
Institutional ownership	59.69 %
Počet akcií	88.949M
Procento shortovaných akcií	3.48 %
Short ratio	4.60 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	2004
Země	Canada

Finanční výsledky akcie APTO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	-	-	-	-	-	-
Cost Of Goods Sold	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Research And Development Expenses	$16.835	$18.733	$6.274	$7.834	$4.901	-
SG&A Expenses	$10.022	$10.374	$5.552	$6.439	$7.715	-
Other Operating Income Or Expenses	-	-	-	-	-	-
Operating Expenses	$26.857	$29.107	$11.826	$14.273	$12.615	-
Operating Income	$-26.857	$-29.107	$-11.826	$-14.273	$-12.615	-
Total Non-Operating Income/Expense	$0.58	$0.239	$0.183	$0.033	$1.154	-
Pre-Tax Income	$-26.277	$-28.868	$-11.643	$-14.24	$-11.461	-
Income Taxes	-	-	-	-	-	-
Income After Taxes	$-26.277	$-28.868	$-11.643	$-14.24	$-11.461	-
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$-26.277	$-28.868	$-11.643	$-14.24	$-11.461	-
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$-26.277	$-28.868	$-11.643	$-14.24	$-11.461	-
EBITDA	$-26.244	$-29.02	$-11.742	$-14.157	$-12.54	-
EBIT	$-26.857	$-29.107	$-11.826	$-14.273	$-12.615	-
Basic Shares Outstanding	50	33	22	13	12	-
Shares Outstanding	50	33	22	13	12	-
Basic EPS	$-0.52	$-0.86	$-0.52	$-1.12	$-0.96	$-1.53
EPS - Earnings Per Share	$-0.52	$-0.86	$-0.52	$-1.12	$-0.96	$-1.53

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$97.6	$15.739	$11.429	$7.94	$15.475	-
Receivables	-	-	-	-	-	-
Inventory	-	-	-	-	-	-
Pre-Paid Expenses	$1.025	$0.646	$0.322	$0.493	$0.836	-
Other Current Assets	$0.141	$0.101	$0.074	-	-	-
Total Current Assets	$98.766	$16.486	$11.825	$8.433	$16.311	-
Property, Plant, And Equipment	$0.334	$0.384	$0.142	$0.213	$0.34	-
Long-Term Investments	-	-	-	-	-	-
Goodwill And Intangible Assets	-	-	-	-	-	-
Other Long-Term Assets	-	-	-	-	-	-
Total Long-Term Assets	$1.71	$0.384	$0.142	$0.213	$0.34	-
Total Assets	$100.476	$16.87	$11.967	$8.646	$16.651	-
Total Current Liabilities	$5.539	$2.789	$1.765	$1.318	$1.846	-
Long Term Debt	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-
Total Long Term Liabilities	$1.011	-	-	-	-	-
Total Liabilities	$6.55	$2.789	$1.765	$1.318	$1.846	-
Common Stock Net	$365.49	$261.072	$231.923	$218.034	$175.076	-
Retained Earnings (Accumulated Deficit)	$-301.915	$-275.638	$-246.77	$-235.127	$-182.508	-
Comprehensive Income	$-4.298	$-4.316	$-4.316	$-4.298	-	-
Other Share Holders Equity	-	-	-	$7.306	$4.968	-
Share Holder Equity	$93.926	$14.081	$10.202	$7.328	$14.805	-
Total Liabilities And Share Holders Equity	$100.476	$16.87	$11.967	$8.646	$16.651	-

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-26.277	$-28.868	$-11.643	$-14.24	$-11.461	-
Total Depreciation And Amortization - Cash Flow	$0.613	$0.087	$0.084	$0.116	$0.075	-
Other Non-Cash Items	$2.218	$4.901	$0.792	$1.86	$1.285	-
Total Non-Cash Items	$2.831	$4.988	$0.876	$1.976	$1.36	-
Change In Accounts Receivable	-	-	-	-	-	-
Change In Inventories	-	-	-	-	-	-
Change In Accounts Payable	$0.645	$0.726	$0.589	$-0.444	$0.208	-
Change In Assets/Liabilities	$1.243	$-0.053	$-0.045	$0.318	$-0.031	-
Total Change In Assets/Liabilities	$1.888	$0.673	$0.544	$-0.126	$0.177	-
Cash Flow From Operating Activities	$-21.558	$-23.207	$-10.223	$-12.39	$-9.924	-
Net Change In Property, Plant, And Equipment	$-0.102	$-0.329	$-0.013	$-0.003	$-0.259	-
Net Change In Intangible Assets	-	-	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	-	-	-
Net Change In Short-term Investments	-	-	-	-	-	-
Net Change In Long-Term Investments	$-17.268	$0.341	$-0.798	-	-	-
Net Change In Investments - Total	$-17.268	$0.341	$-0.798	-	-	-
Investing Activities - Other	-	-	-	$6.48	$6.442	-
Cash Flow From Investing Activities	$-17.37	$0.012	$-0.811	$6.477	$6.183	-
Net Long-Term Debt	-	-	-	-	-	-
Net Current Debt	-	-	-	-	-	-
Debt Issuance/Retirement Net - Total	-	-	-	-	-	-
Net Common Equity Issued/Repurchased	$103.885	$27.886	$14.025	$5.726	$0.789	-
Net Total Equity Issued/Repurchased	$103.885	$27.886	$14.025	$5.726	$0.789	-
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	$-0.437	$-0.015	$-0.307	-	$-0.02	-
Cash Flow From Financial Activities	$103.448	$27.871	$13.718	$5.726	$0.77	-
Net Cash Flow	$64.543	$4.668	$2.691	$-0.371	$-2.243	-
Stock-Based Compensation	$2.296	$4.276	$0.817	$1.706	$2.204	-
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	17.831	5.9111	6.6997	6.3983	8.8349	-
Long-term Debt / Capital	-	-	-	-	-	-
Debt/Equity Ratio	-	-	-	-	-	-
Gross Margin	-	-	-	-	-	-
Operating Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
EBITDA Margin	-	-	-	-	-	-
Pre-Tax Profit Margin	-	-	-	-	-	-
Net Profit Margin	-	-	-	-	-	-
Asset Turnover	-	-	-	-	-	-
Inventory Turnover Ratio	-	-	-	-	-	-
Receiveable Turnover	-	-	-	-	-	-
Days Sales In Receivables	-	-	-	-	-	-
ROE - Return On Equity	-27.9763	-205.0138	-114.1248	-194.3233	-77.4149	-
Return On Tangible Equity	-27.9763	-205.0138	-114.1247	-194.3231	-77.4149	-
ROA - Return On Assets	-26.1525	-171.1203	-97.2926	-164.7004	-68.8315	-
ROI - Return On Investment	-27.9763	-205.0139	-114.1247	-194.3231	-77.4149	-
Book Value Per Share	1.2341	0.369	0.371	0.4662	1.2288	-
Operating Cash Flow Per Share	0.2652	-0.2368	0.5141	-0.1388	-0.8335	-
Free Cash Flow Per Share	0.2731	-0.2462	0.5138	-0.1173	-0.8552	-

Warning: Undefined array key "user" in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php on line 716

Fatal error: Uncaught mysqli_sql_exception: You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'AND valid >= CURDATE()' at line 2 in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php:11 Stack trace: #0 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php(11): mysqli_query(Object(mysqli), 'SELECT * FROM p...') #1 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php(716): Database::Execute(Object(mysqli), 'SELECT * FROM p...') #2 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(20): require_once('/data/web/virtu...') #3 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): {closure}() #4 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): Closure->__invoke() #5 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(21): Route::set('graf-akcie/APTO', Object(Closure)) #6 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/index.php(23): require_once('/data/web/virtu...') #7 {main} thrown in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php on line 11

JenAkcie

Graf Akcie APTO (Aptose Biosciences Inc). Diskuze k akciím APTO. Aktuální informace APTO.

Základní informace o společnosti Aptose Biosciences Inc (Akcie APTO)

Finanční výsledky akcie APTO